Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mabvax Therapeutics Holdings Inc (MBVX)

Mabvax Therapeutics Holdings Inc (MBVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mabvax Therapeutics Holdings Inc 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 USA

www.mabvax.com P: 858-259-9405

Description:

MabVax Therapeutics Holdings, Inc. is a clinical-stage drug development company. It is focused on discovering and developing small molecule drugs to treat cancer. TELINTRA is the Company's lead small molecule product candidate in clinical development for the treatment of blood disorders, including cancer. MabVax Therapeutics Holdings, Inc., formerly known as Telik, Inc., is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 1,024
Shares Outstanding, K 9,255
Annual Sales, $ 0 K
Annual Net Income, $ -19,020 K
Last Quarter Sales, $ 4,000 K
Last Quarter Net Income, $ 340 K
60-Month Beta 4.32
% of Insider Shareholders 14.76%
% of Institutional Shareholders 0.39%
Float, K 7,889
% Float 85.24%

Growth:

1-Year Return -93.57%
3-Year Return -99.30%
5-Year Return -99.95%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 03/26/19
Earnings Per Share ttm 0.02
EPS Growth vs. Prev Year 101.23%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-3 on 02/16/18

MBVX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -2,992.79%
Return-on-Assets % -120.65%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales 0.22
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage -19.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar